The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization

Subhash Banerjee, Karan Sarode, Ariel Vinas, Avantika Banerjee, Atif Mohammad, Emmanouil S. Brilakis

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Eligible patients with symptomatic PAD or with a history of peripheral artery revascularization should be prescribed antiplatelet monotherapy for secondary prevention of both cardiovascular and limb events, using aspirin, clopidogrel, and/or vorapaxar. Given the significant overlap of PAD and coronary artery disease, the evidence presented in this article may have important implications for management of patients with coronary artery disease.

Original languageEnglish (US)
Pages (from-to)525-535
Number of pages11
JournalCurrent Opinion in Cardiology
Volume30
Issue number5
DOIs
StatePublished - Aug 24 2015

Keywords

  • Antiplatelet therapy
  • Endovascular revascularization
  • Peripheral artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization'. Together they form a unique fingerprint.

  • Cite this